Merck & Co., Inc. Stock Forecast, Price & News

Merck & Co., Inc. (NYSE:MRK) Frequently Asked Questions

Is Merck & Co., Inc. a buy right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merck & Co., Inc. in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Merck & Co., Inc. stock.
View analyst ratings for Merck & Co., Inc. or view top-rated stocks.

How has Merck & Co., Inc.'s stock price been impacted by Coronavirus?

Merck & Co., Inc.'s stock was trading at $79.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MRK stock has decreased by 0.1% and is now trading at $79.16.
View which stocks have been most impacted by COVID-19.

When is Merck & Co., Inc.'s next earnings date?

Merck & Co., Inc. is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Merck & Co., Inc..

How were Merck & Co., Inc.'s earnings last quarter?

Merck & Co., Inc. (NYSE:MRK) issued its earnings results on Wednesday, October, 27th. The company reported $1.75 earnings per share for the quarter, topping analysts' consensus estimates of $1.55 by $0.20. The company had revenue of $13.15 billion for the quarter, compared to analyst estimates of $12.32 billion. Merck & Co., Inc. had a trailing twelve-month return on equity of 48.21% and a net margin of 14.64%. Merck & Co., Inc.'s revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.74 earnings per share.
View Merck & Co., Inc.'s earnings history.

How often does Merck & Co., Inc. pay dividends? What is the dividend yield for Merck & Co., Inc.?

Merck & Co., Inc. declared a quarterly dividend on Tuesday, July 27th. Shareholders of record on Wednesday, September 15th will be given a dividend of $0.65 per share on Thursday, October 7th. This represents a $2.60 annualized dividend and a dividend yield of 3.28%. The ex-dividend date is Tuesday, September 14th.
View Merck & Co., Inc.'s dividend history.

Is Merck & Co., Inc. a good dividend stock?

Merck & Co., Inc. pays an annual dividend of $2.60 per share and currently has a dividend yield of 3.16%. Merck & Co., Inc. has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Merck & Co., Inc. is 91.87%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, Merck & Co., Inc. will have a dividend payout ratio of 39.16% next year. This indicates that Merck & Co., Inc. will be able to sustain or increase its dividend.
View Merck & Co., Inc.'s dividend history.

What guidance has Merck & Co., Inc. issued on next quarter's earnings?

Merck & Co., Inc. updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of $5.650-$5.700 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.770. The company issued revenue guidance of $47.40 billion-$47.90 billion, compared to the consensus revenue estimate of $48.16 billion.

What price target have analysts set for MRK?

11 brokerages have issued twelve-month price targets for Merck & Co., Inc.'s shares. Their forecasts range from $90.00 to $110.00. On average, they expect Merck & Co., Inc.'s stock price to reach $97.10 in the next year. This suggests a possible upside of 22.7% from the stock's current price.
View analysts' price targets for Merck & Co., Inc. or view top-rated stocks among Wall Street analysts.

Who are Merck & Co., Inc.'s key executives?

Merck & Co., Inc.'s management team includes the following people:

• Robert M. Davis, President, Chief Executive Officer & Director
• Caroline A. Litchfield, Chief Financial Officer & Executive Vice President
• Sandy Tremps, Vice President-R&D IT CIO
• Dave Williams, Chief Information & Digital Officer
• Franklin K. Clyburn, Executive VP & President-Human Health

What is Kenneth C. Frazier's approval rating as Merck & Co., Inc.'s CEO?

1,343 employees have rated Merck & Co., Inc. CEO Kenneth C. Frazier on Glassdoor.com. Kenneth C. Frazier has an approval rating of 94% among Merck & Co., Inc.'s employees. This puts Kenneth C. Frazier in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Merck & Co., Inc.'s key competitors?

Some companies that are related to Merck & Co., Inc. include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Supernus Pharmaceuticals (SUPN) and Endo International (ENDP).
View all of MRK's competitors.

What other stocks do shareholders of Merck & Co., Inc. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merck & Co., Inc. investors own include Pfizer (PFE), Johnson & Johnson (JNJ), AT&T (T), Intel (INTC), Cisco Systems (CSCO), Walt Disney (DIS), Verizon Communications (VZ), JPMorgan Chase & Co. (JPM), AbbVie (ABBV) and Home Depot (HD).

What is Merck & Co., Inc.'s stock symbol?

Merck & Co., Inc. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRK."

Who are Merck & Co., Inc.'s major shareholders?

Merck & Co., Inc.'s stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.42%), Wellington Management Group LLP (1.96%), Geode Capital Management LLC (1.69%), Franklin Resources Inc. (1.55%), Bank of New York Mellon Corp (1.16%) and Morgan Stanley (1.03%). Company insiders that own Merck & Co., Inc. stock include Caroline Litchfield, Frank Clyburn, Julie L Gerberding, Kenneth C Frazier, Richard R Deluca, Rita A Karachun, Robert M Davis, Sanat Chattopadhyay and Wendell P Weeks.
View institutional ownership trends for Merck & Co., Inc..

Which institutional investors are selling Merck & Co., Inc. stock?

MRK stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., AMF Pensionsforsakring AB, Geode Capital Management LLC, Prospera Financial Services Inc, KBC Group NV, Man Group plc, Hsbc Holdings PLC, and Schroder Investment Management Group. Company insiders that have sold Merck & Co., Inc. company stock in the last year include Caroline Litchfield, Frank Clyburn, Kenneth C Frazier, Richard R Deluca, Rita A Karachun, and Sanat Chattopadhyay.
View insider buying and selling activity for Merck & Co., Inc. or view top insider-selling stocks.

Which institutional investors are buying Merck & Co., Inc. stock?

MRK stock was bought by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Invesco Ltd., Capital World Investors, Marathon Asset Mgmt Ltd, Credit Suisse AG, California Public Employees Retirement System, Bank of Nova Scotia, and Arrowstreet Capital Limited Partnership.
View insider buying and selling activity for Merck & Co., Inc. or or view top insider-buying stocks.

How do I buy shares of Merck & Co., Inc.?

Shares of MRK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merck & Co., Inc.'s stock price today?

One share of MRK stock can currently be purchased for approximately $79.16.

How much money does Merck & Co., Inc. make?

Merck & Co., Inc. has a market capitalization of $199.95 billion and generates $47.99 billion in revenue each year. The company earns $7.07 billion in net income (profit) each year or $2.83 on an earnings per share basis.

How many employees does Merck & Co., Inc. have?

Merck & Co., Inc. employs 74,000 workers across the globe.

When was Merck & Co., Inc. founded?

Merck & Co., Inc. was founded in 1891.

What is Merck & Co., Inc.'s official website?

The official website for Merck & Co., Inc. is www.merck.com.

Where are Merck & Co., Inc.'s headquarters?

Merck & Co., Inc. is headquartered at 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033.

How can I contact Merck & Co., Inc.?

Merck & Co., Inc.'s mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The company can be reached via phone at (908) 740-4000, via email at [email protected], or via fax at 908-735-1253.